Congress organisers are obliged to inform potential congress participants, in advance, about the scope and terms of the support of the pharmaceutical industry (FSA). We fulfil this obligation and therefore inform you about the amount of the sponsorship of companies involved as well as the companies that voluntarily wish to publish:
| Moderna Germany GmbH | 12.500,00 € |
| MSD Sharp & Dohme GmbH | 11.000,00 € |
| Selvita S.A. | 4.500,00 € |
| Biozym Scientific GmbH | 2.500,00 € |
| Esteve Pharmaceuticals GmbH | 2.500,00 € |
| Sino Biological Europe GmbH | 2.500,00 € |
| SARSTEDT AG & Co .KG | 2.000,00 € |
| Novogene Europe | 2.000,00 € |
| BioLegend GmbH | 1.500,00 € |
| New England Biolabs GmbH | 500,00 € |